In: PATENT NEWS
Clovis Oncology announces second US patent issued in Rucaparib high dosage strength tablet Seeking Alpha Clovis Oncology Announces Second US Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family with … Business Wire (press release) Clovis Oncology (CLVS) Announces Second US Patent Issued in Rucaparib High Dosage Strength Tablet Patent Family StreetInsider.com... Continue reading
In: PATENT NEWS
GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time … PRNewswire (press release) GB Sciences files patent application for the treatment of neuropathic pain using myrcene-based nanoparticles Seeking Alpha Full coverage
In: PATENT NEWS
New US patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted P&T Community Full coverage
In: PATENT NEWS
Justices Won’t Hear Challenge To Fed. Circ. Drug Patent Test Law360 Full coverage
In: PATENT NEWS
Justices Won’t Examine ‘Multiple Proceedings’ Patent Rule Law360 Full coverage
In: PATENT NEWS
Prosecution Strategies for Avoiding Patent Eligibility Rejections for Diagnostics The National Law Review Mixed Result in Finjan Patent Appeal Bloomberg Law Massive SportBrain Patent Litigation Officially Ends Law.com Full coverage
In: PATENT NEWS
Disney Files Patent for Retractable Internally-Illuminated Lightsaber wdwnt.com Full coverage
In: PATENT NEWS
Patent and trademark – Infringement Massachusetts Lawyers Weekly Full coverage
In: PATENT NEWS
Nasdaq Wants Fish & Richardson DQ’d From Patent Fight Law360 Full coverage
In: PATENT NEWS
Global Patent Prosecution Newsletter – November 2018: Blockchain-ing Alice? JD Supra (press release) Full coverage
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION